You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 161 No. 3, March 2007 TABLE OF CONTENTS
  Archives
  •  Online Features
  Special Feature
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Picture of the Month
 •Infectious Diseases
 •Bacterial Infections
 •Tuberculosis/ Other Mycobacterium
 •Diagnosis
 •Pediatrics, Other
 •Alert me on articles by topic

Picture of the Month—Diagnosis


Arch Pediatr Adolesc Med. 2007;161(3):304.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Denouement and Discussion: Severe Skin Ulceration After Tuberculin Skin Test

The patient's primary diagnosis was lymphadenitis caused by Mycobacterium tuberculosis. The skin necrosis was related to tuberculin skin testing.

A bulla (22 mm in diameter) developed 4 days after a PPD injection (Figure, A and B). The erythema extended, covering almost all the volar forearm, from the elbow down to the wrist (black mark in Figure, A). The full thickness of the skin covering the bulla dislodged 2 days later, with granulation tissue and some yellowish eschar left (Figure, C on day 7 postinjection). Vancomycin hydrochloride was administered empirically for 2 days to treat presumed cellulitis. Cultures of blood and swab tests from the base of the bulla were negative for microorganisms. A biopsy specimen of the right cervical lesions revealed granulomatous inflammation, caseous necrosis, multinuclear giant cells, and acid-fast bacilli suggestive of mycobacterial infection. The patient was treated with isoniazid, rifampin, ethambutol hydrochloride, and . . . [Full Text of this Article]


AUTHOR INFORMATION






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2007 American Medical Association. All Rights Reserved.